PROF

Profound Medical Corp. PROF

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,500 of 2,925

Why it scores 30Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$2.48M

Quarter to Jun 30

Net income

$-9.54M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$105.77M total
FIL Ltd
$15.76M+1.3%
GAGNON SECURITIES LLC
$13.03M+0.8%
ROYCE & ASSOCIATES LP
$7.98M+7.5%
Timelo Investment Management Inc.
$7.41M0.0%
Gagnon Advisors, LLC
$6.40M0.0%
Rosalind Advisors, Inc.
$5.51M0.0%
Z3 Capital Partners, LLC
$5.46M+0.4%
LETKO, BROSSEAU & ASSOCIATES INC
$5.40M-1.8%
MMCAP International Inc. SPC
$4.46M-9.9%
ARDSLEY ADVISORY PARTNERS LP
$3.82M0.0%
Ring Mountain Capital, LLC
$3.40M+0.2%
Lagoda Investment Management, L.P.
$3.33M+13.7%
ROYAL BANK OF CANADA
$3.27M-0.3%
First Eagle Investment Management, LLC
$2.93M+36.4%
DAFNA Capital Management LLC
$1.73M-1.0%
Bleichroeder LP
$1.69M0.0%
FORMULA GROWTH LTD
$1.60M-0.4%
THOMPSON DAVIS & CO., INC.
$1.44M+0.3%
Dauntless Investment Group, LLC
$1.39M-13.4%
RAYMOND JAMES FINANCIAL INC
$1.26M+25.9%
NATIONAL BANK OF CANADA /FI/
$1.25M+0.7%
CM Management, LLC
$1.16M0.0%
Velan Capital Investment Management LP
$1.13M-40.4%
TD Waterhouse Canada Inc.
$933.6K-3.4%
PERKINS CAPITAL MANAGEMENT INC
$760.0K0.0%
See all 56 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/PROF

Earnings Per Share

13fpro.ai/company/PROF

Loading ratio trend…

PROF key financials by period

Reported revenue, net income and operating margin by fiscal year, from Profound Medical Corp.'s annual filings on SEC EDGAR.

Profound Medical Corp. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$16.1M$-42.6M—
FY 2024$10.7M$-27.8M—
FY 2023$7.2M$-28.3M—
FY 2022$6.7M$-28.7M—
FY 2021$6.9M$-30.7M—
FY 2020$7.3M$-21.6M—
Source: PROF filings on SEC EDGAR →

About Profound Medical Corp. (PROF): stock profile, AI score and financials

Profound Medical Corp. (PROF) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PROF at 29.5/100 on a composite quality score built from its SEC filings, placing it at rank #2,500 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Profound Medical Corp. reports quarterly revenue of $2.5M, net income of $-9.5M. Top institutional holders of PROF by reported 13-F value include FIL Ltd, GAGNON SECURITIES, ROYCE & ASSOCIATES, based on the most recent SEC filings. PROF trades on the Nasdaq exchange and files with the SEC under CIK 1628808. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PROF daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Profound Medical Corp. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1628808 →